If you're choosing between the Medtronic MiniMed 780G and the Tandem t:slim X2, you're comparing two of the most established advanced automated insulin delivery systems available. Both are tubed pumps with proven algorithms, strong clinical track records, and loyal user bases. But they differ in important ways: the CGM each uses, how aggressively each can target glucose, how meals are handled, and infusion set wear time. Understanding those differences helps you and your care team choose the system that fits your needs best. This guide breaks it all down.
MiniMed 780G vs. t:slim X2: Side-by-Side
According to the ADA Consumer Guide listings for both systems, here's how they compare on the features that matter most:
| Feature | Medtronic MiniMed 780G | Tandem t:slim X2 with Control-IQ |
|---|---|---|
| Algorithm | SmartGuard (adjusts every 5 min) | Control-IQ (predicts 30 min ahead) |
| Compatible CGM | Guardian 4 sensor | Dexcom G6/G7, FreeStyle Libre 2/3 Plus |
| Glucose Targets | Adjustable: 100, 110, or 120 mg/dL | Fixed target during automation (110 mg/dL) |
| Meal Detection | Yes (auto-corrects for missed/miscalculated boluses) | No automatic meal detection; auto-corrections up to once per hour |
| Reservoir Capacity | 300 units (MMT-332A) or 180 units (MMT0326A) | 300 units |
| Infusion Set Wear | Up to 7 days (Extended infusion set) | 2 to 3 days (standard sets) |
| On-Device Control | Yes (on-pump buttons and screen) | Yes (touchscreen) |
| Care Partner Sharing | Up to 5 care partners via CareLink | Data sharing via t:connect |
| Typical Time in Range | Around 75 to 80% reported | Improved TIR in real-world studies |
| Approved Ages | Type 1, ages 7+ (using 8+ units/day) | Type 1 ages 2+; Type 2 adults 18+ |
Medtronic MiniMed 780G: Aggressive Targets and Long Infusion Set Wear
The Medtronic MiniMed 780G uses SmartGuard technology, which adjusts insulin every five minutes based on readings from the Guardian 4 sensor. According to the ADCES, the Guardian 4 requires no fingersticks while in SmartGuard mode, and the system received FDA approval in 2023 for people with type 1 diabetes ages 7 and older using at least 8 units of insulin per day.
Two features distinguish the 780G most clearly. First, it offers adjustable glucose targets of 100, 110, or 120 mg/dL, and the ADCES notes it is the only system on the market with a target setting as low as 100 mg/dL, which more closely mirrors the average glucose of someone without diabetes. For users and care teams aiming for tighter control, this lower target option is a genuine differentiator.
Second, the 780G features meal detection technology. The ADA Consumer Guide explains that the system automatically detects meals based on glucose rate of change and delivers correction doses, compensating for miscalculated carbs or missed boluses. This adds a layer of forgiveness for the imperfect carb counting that happens in real life, though it does not eliminate the need to bolus for meals.
The 780G also pairs with the Medtronic Extended infusion set, which can be worn for up to seven days, double the wear time of standard two-to-three-day sets. For users who'd rather change their infusion site less often, this is a meaningful convenience and may reduce supply use over time. It uses the Extended reservoir and is compatible with Humalog, Novolog, Fiasp, and Lyumjev insulins. A systematic review published in PubMed Central found that the 780G consistently achieves time in range around 75 to 80%, with reductions in nighttime hypoglycemia and improvements in sleep quality and treatment satisfaction reported by users and caregivers.
One consideration: the 780G works only with the Guardian 4 sensor. If you have a strong preference for a Dexcom or FreeStyle Libre CGM, the 780G's closed ecosystem is a factor to weigh.
Tandem t:slim X2 with Control-IQ: CGM Flexibility and a Proven Algorithm
The Tandem t:slim X2 with Control-IQ takes a different approach in several respects. Its Control-IQ algorithm predicts glucose levels 30 minutes into the future and adjusts basal insulin accordingly, delivering automatic correction boluses up to once per hour when glucose is predicted to run high. It carries one of the largest real-world evidence bases of any AID system, with studies consistently showing improved time in range and reduced hypoglycemia.
The t:slim X2's standout advantage is CGM flexibility. According to the ADA Consumer Guide, it integrates with the Dexcom G6, Dexcom G7, and both the FreeStyle Libre 2 Plus and Libre 3 Plus. This means you can choose from multiple popular CGMs rather than being tied to a single proprietary sensor, which is appealing if you already use and like a Dexcom or Abbott device.
The t:slim X2 has a 3.7-inch color touchscreen for on-device control, a 300-unit reservoir, and is approved for a broader age range than the 780G: type 1 diabetes ages 2 and older, and type 2 adults 18 and older. During automation, Control-IQ works toward a fixed target rather than offering the adjustable lower targets of the 780G, though it includes dedicated sleep and exercise activity settings that adjust its behavior for those situations.
Where the t:slim X2 differs from the 780G is in meal handling and infusion set wear. It does not have automatic meal detection in the way the 780G does, relying instead on user-initiated boluses plus its hourly automatic corrections. And its standard infusion sets, like the AutoSoft XC, are worn for the typical two to three days rather than up to seven. It uses the t:slim X2 cartridge with the t:lock connector.
Which System Fits Your Priorities
Both systems deliver excellent clinical outcomes, so the choice comes down to which features matter most to you. The MiniMed 780G stands out for its adjustable lower glucose targets (the only system that goes as low as 100 mg/dL), its meal detection technology that forgives imperfect carb counting, and its seven-day infusion set wear. The t:slim X2 stands out for its CGM flexibility (working with both Dexcom and FreeStyle Libre), its broader age approval, and one of the deepest real-world evidence bases in the category. If you want the lowest target and longest infusion set wear, the 780G leans your way. If CGM choice and a touchscreen interface matter most, the t:slim X2 leans yours. Your diabetes care team can help match the system to your clinical goals and lifestyle. Explore our Learning Center and Education page for more pump comparisons.
Frequently Asked Questions About the MiniMed 780G and t:slim X2
Which system has better blood sugar control?
Both systems produce strong outcomes, and neither is universally "better." The MiniMed 780G has been reported to achieve time in range around 75 to 80% in studies, and its adjustable target as low as 100 mg/dL can support tighter control for those who want it. The t:slim X2 with Control-IQ also consistently improves time in range and reduces hypoglycemia in real-world studies. The better choice depends on your individual response, preferences, and clinical goals rather than a single performance number. Your care team can help you weigh the options for your situation.
Can I use a Dexcom sensor with the MiniMed 780G?
No. The MiniMed 780G works exclusively with the Medtronic Guardian 4 sensor. If you prefer to use a Dexcom G6 or G7, or a FreeStyle Libre sensor, the t:slim X2 with Control-IQ is the system that offers that flexibility. CGM compatibility is one of the clearest practical differences between the two pumps, so if you have a strong CGM preference, it may guide your decision more than any other factor.
What is meal detection and does only the 780G have it?
Meal detection is a feature of the MiniMed 780G that automatically recognizes a glucose rise consistent with a meal and delivers additional correction insulin, helping compensate for a missed or underestimated mealtime bolus. The t:slim X2 does not have automatic meal detection in the same way, though it delivers automatic correction boluses up to once per hour through Control-IQ. It's worth noting that no current system eliminates the need to bolus for meals; meal detection is a backstop for imperfect carb counting, not a replacement for mealtime dosing.
How much longer can I wear the 780G infusion set?
The MiniMed 780G is compatible with the Medtronic Extended infusion set, which can be worn for up to seven days, compared to the typical two to three days for standard sets like those used with the t:slim X2. This means fewer site changes and potentially less supply use over time. The Extended set uses advanced materials designed to maintain insulin flow and reduce the risk of occlusion over the longer wear period. For people who find frequent infusion set changes burdensome, this is a meaningful convenience advantage.
Are both systems covered by insurance?
Both the MiniMed 780G and the t:slim X2 are covered by most private insurance plans, Medicare, and many Medicaid programs for eligible patients, though coverage criteria and prior authorization requirements vary by plan and by your diabetes type. Insulin pump coverage generally requires documentation of medical necessity. Our team at Adapt Health Diabetes verifies your specific coverage before any order ships and can help you understand what you qualify for. Contact us to get started.
Get Your Pump and Supplies Through Adapt Health Diabetes
Whichever closed-loop system fits you best, Adapt Health Diabetes carries it along with all the supplies you'll need, verified through your insurance and delivered to your door. Browse our Medtronic MiniMed and Tandem Diabetes collections, or visit our Resources page for more information. Questions about which system is right for you? Contact our team.
This article is for educational purposes only and does not replace professional medical advice. Always consult your healthcare provider regarding insulin pump selection and diabetes management decisions.
Sources
- American Diabetes Association. MiniMed 780G System. ADA Consumer Guide.
- American Diabetes Association. t:slim X2 Insulin Pump With Control-IQ. ADA Consumer Guide.
- American Association of Diabetes Care and Education Specialists. FDA Approves Medtronic MiniMed 780G System. danatech by ADCES. 2023.
- Petrovski G, et al. Safety, Metabolic and Psychological Outcomes of Medtronic MiniMed 780G in Children, Adolescents and Young Adults: A Systematic Review. PubMed Central. 2024.
